EXOZ

Exozymes Inc Cross-source read$6.30 2.14%
Health CareCUSIP 461874109· EOD Sep 11, 2026

Among active 13F managers last quarter, 1 opened and 1 added, while none reduced or exited; the largest holder to move was Davidson Kahn Capital Management, LLC (new position). Over the last 180 days, 1 insider sold and 1 insider bought, a net -$9K in open-market trades.

Tracked 13F holders
8
2 in Q2 2026 filings
13F value (tracked)
$1.1M
Smart-money readMixed
Net sellingNet buying
Funds · active managers, latest 13F
2 adding · 0 trimming
Insiders · Form 4 open-market, 180d
1 buying · 1 selling · -$9K
US House · STOCK Act, 180d
0 buying · 0 selling

The legs disagree, or only one of them leans.

Price & smart-money activity

$6.30 2.14%2Y -27.1%
$3.14$7.70$12.25$16.81$21.37Nov 2024Mar 2025AugDecApr 2026Sep22225
Hover for who · click for detailEnd-of-day closing prices52w $4.40 – $16.50

Who owns EXOZ?

8 tracked 13F filers · ranked by shares held

8 tracked 13F filers disclose a position in EXOZ as of the latest SEC 13F filings, a combined $1.1M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

#FundSharesPosition valueLast moveAs ofHistory
1Vanguard Capital Management LLC55K
$464K
+148%
Added · +33K sh
Q2 2026
2Davidson Kahn Capital Management, LLC25K
$211K
New
+25K sh
Q2 2026
3Geode Capital Management, LLC23K
$197K
+6.9%
Added · +2K sh
Q2 2026
4BlackRock, Inc.10K
$81K
+41%
Added · +3K sh
Q2 2026
5Vanguard Fiduciary Trust Co9K
$79K
Held
Q2 2026
6Tower Research Capital LLC (TRC)1K
$10K
659×
Added · +1K sh
Q1 2026
7Morgan Stanley1K
$9K
Held
Q1 2026
8UBS Group AG24
$180
+700%
Added · +21 sh
Q1 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is EXOZ being bought or sold by institutions?

Last quarter, 1 fund opened a new position in EXOZ and 1 added to an existing one, while none reduced or exited. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Opened
1
fund took a first position
Added
1
added to an existing position
Biggest moves · ranked by size of the change, positions above a floor

Funds that own EXOZ also own

CompanyCo-held byTheir position there
Invesco QQQ Trust Series 1QQQ2 funds$158.8M
Apple IncAAPL2 funds$115.3M
Microsoft CorpMSFT2 funds$97.6M
Tesla IncTSLA2 funds$71.2M
Nvidia CorpNVDA2 funds$67.9M
Alphabet Inc-CL AGOOGL2 funds$57.8M
Broadcom IncAVGO2 funds$57.7M
Amazon.com IncAMZN2 funds$42.9M
SS SPDR S&P 500 ETF Trust-USSPY2 funds$38.4M
Meta Platforms Inc-Class AMETA2 funds$32.3M
JPMorgan Chase & CoJPM2 funds$29.9M
Alphabet Inc-CL CGOOG2 funds$27.3M

Ranked by how many of EXOZ's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in EXOZ.

Insider activity (Form 4)

Full insider page →
Buys · 180d
$6K
1 insider
Sells · 180d
$15K
1 insider
Net · 180d
-$9K
7 open-market transactions
DateInsiderRoleActionSharesValue
Aug 26, 2026Heltzen MichaelChief Executive OfficerBuy (P)
3 lots, same day
505$4K
Aug 25, 2026Heltzen MichaelChief Executive OfficerBuy (P)
2 lots, same day
350$3K
Apr 9, 2026Korman Tyler PazChief Scientific OfficerSell (S)750$8K
Apr 8, 2026Korman Tyler PazChief Scientific OfficerSell (S)750$8K
Jul 2, 2025Heltzen MichaelChief Executive OfficerBuy (P)1K$11K
Jan 17, 2025Heltzen MichaelChief Executive OfficerBuy (P)2K$19K
Jan 16, 2025Heltzen MichaelChief Executive OfficerBuy (P)121$1K
Nov 15, 2024Heltzen MichaelChief Executive OfficerBuy (P)2K$22K

One row per insider, day and transaction code; shares and value are summed across the lots. Every lot is on the full insider page and in the filing.

Do institutions, insiders and Congress agree?

Mixed signals

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
50
Insiders
Form 4 open-market
11-$9K
US House
STOCK Act trades
00$0
Sector rotation
EXOZ is in Health Care, which smart money is rotating OUT OF
$5.0B

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Institutional ownership over time

2 tracked filers in Q2 2026 filingsstill filing
059Q4 2024Q2 2025Q4 2025Q2 2026
tracked filers holding their reported valueQ2 2026 filings so far: $408K
Each bar counts tracked filers with a position in that quarter's filings, so the newest bar excludes filers still on an earlier quarter. Arkolith's tracked universe has grown over this window; part of any long-run rise is coverage, not new buyers.

Recent filings

14 most recent

Keep exploring

Connected entities for EXOZ

Browse more

Build

Ask your agent what changed in EXOZ

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/EXOZ/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for EXOZ.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for EXOZ. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.